Tobias Welte

Active 1996–2025

400
Papers
63,008
Citations
128
h-index
387
i10-index

Citations

Citations per year for Tobias Welte1916: 2 citations1996: 1 citations1997: 3 citations1998: 1 citations1999: 1 citations2000: 7 citations2001: 7 citations2002: 16 citations2003: 19 citations2004: 25 citations2005: 51 citations2006: 88 citations2007: 111 citations2008: 180 citations2009: 270 citations2010: 264 citations2011: 311 citations2012: 298 citations2013: 313 citations2014: 267 citations2015: 289 citations2016: 289 citations2017: 334 citations2018: 319 citations2019: 1,210 citations2020: 2,243 citations2021: 2,771 citations2022: 2,183 citations2023: 1,673 citations2024: 2,702 citations2025: 1,305 citations2026: 43 citations1917–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,842 citing papers, 17.2% of this breakdownGermany: 2,182 citing papers, 7.7% of this breakdownUnited Kingdom: 2,149 citing papers, 7.6% of this breakdownChina: 1,967 citing papers, 7% of this breakdownItaly: 1,722 citing papers, 6.1% of this breakdownFrance: 1,428 citing papers, 5.1% of this breakdownSpain: 1,219 citing papers, 4.3% of this breakdownCanada: 990 citing papers, 3.5% of this breakdownNetherlands: 890 citing papers, 3.2% of this breakdownAustralia: 846 citing papers, 3% of this breakdownSwitzerland: 745 citing papers, 2.6% of this breakdownBelgium: 699 citing papers, 2.5% of this breakdown
0%17.2%Other 30.2%

Fields

  • Medicine78%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Immunology and Microbiology5.4%
  • Engineering2%
  • Nursing0.7%
  • Health Professions0.6%
  • Other3.7%

Topics

  • COVID-19 Clinical Research Studies5.8%
  • Sepsis Diagnosis and Treatment4.5%
  • Respiratory Support and Mechanisms3.8%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.2%
  • Nosocomial Infections in ICU3.1%
  • Long-Term Effects of COVID-193%
  • Other76.6%

Coauthors

All papers

Open in search
  1. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles D. Gomersall, Carol Hodgson, Morten Hylander Møller, Theodore J. Iwashyna, Shevin T. Jacob, Ruth Kleinpell, Michael Klompas, Younsuck Koh, Anand Kumar, Arthur Kwizera, Suzana Margareth Lobo, Henry Masur, Steven McGloughlin, Sangeeta Mehta, Yatin Mehta, Mervyn Mer, Mark Nunnally, Simon Oczkowski, Tiffany M. Osborn, Elizabeth Papathanassoglou, Anders Perner, Michael A. Puskarich, Jason A. Roberts, William D. Schweickert, Maureen A. Seckel, Jonathan Sevransky, Charles L. Sprung, Tobias Welte, Janice L. Zimmerman, Mitchell M. Levy - Critical Care Medicine 2021 cited by 5,021

  2. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 5,870

  3. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,395

  4. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 650

  5. European Respiratory Society guidelines for the management of adult bronchiectasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,344

  6. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Klaus F. Rabe, Francesco Bonella, R. Bonnet, Christian Grohé, Matthias Held, Heinrike Wilkens, Peter Hammerl, Dirk Koschel, Stefan Blaas, Hubert Wirtz, Joachim H. Ficker, Wolfgang Neumeister, N Schönfeld, Martin Claussen, Nikolaus Kneidinger, Marion Frankenberger, Simone Hummler, Nicolas Kahn, Silke Tello, Julia Freise, Tobias Welte, Petra Neuser, Andreas Günther, Carmen Schade‐Brittinger, Behnaz Aminossadati, Christian Nasemann, Soraya Yahiaoui, Christoph Dupuy Backofen, Maik Hahmann, Michael Wittenberg, Fotis Drakopanagiotakis, Daniel von der Beck, Stefanie Ghofrani, S Heinemann, Ekaterina Krauss, Hella Rethorn, Andrea Koch, Gabriela Leuschner, Sandhya Matthes, Claus Neurohr, Tobias Veit, Katrin Milger, Felix Herth, Julia Benstz, Simone Hummler, Thomas Bahmer, Heike Biller, Benjamin Waschki, Rosa-Marie Apel, Ulrich Costabel, Eva Börner, Thomas Wessendorf, M. Arnrich, Lacramioara Ilie, Alexandra Wald, Hans‐Jürgen Seyfarth, Christian Reinhardt, Atif Cinar, Markus Vogler, Siegfried Matthias Huhn, Jaqueline Richter, U Neff, Torsten Blum, Silvan Vesenbeckh, Christian Boch, Hannes Semper, Andreas Wilke, Michael Pfeifer, Annette Schweda, Angelika Krill and 7 more - The Lancet Respiratory Medicine 2021 cited by 516

  7. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2023 cited by 280

  8. Weaning from mechanical ventilation

    Authors: , , , , , , , , , , - European Respiratory Journal 2007 cited by 2,113

  9. Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles D. Gomersall, Carol Hodgson, Morten Hylander Møller, Theodore J. Iwashyna, Shevin T. Jacob, Ruth Kleinpell, Michael Klompas, Younsuck Koh, Anand Kumar, Arthur Kwizera, Suzana M Lobo, Henry Masur, Steven McGloughlin, Sangeeta Mehta, Yatin Mehta, Mervyn Mer, Mark Nunnally, Simon Oczkowski, Tiffany M. Osborn, Elizabeth Papathanassoglou, Anders Perner, Michael A. Puskarich, Jason A. Roberts, William D. Schweickert, Maureen A. Seckel, Jonathan Sevransky, Charles L. Sprung, Tobias Welte, Janice L. Zimmerman, Mitchell M. Levy - Critical Care Medicine 2021 cited by 494

  10. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Welte, Robert C. Wilson, Conroy Wong, James D. Chalmers - The Lancet Respiratory Medicine 2021 cited by 285

  11. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bonavuth Pek, Guy Chouinard, Amarjit Cheema, William H. Yang, George Philteos, Pascal Chanez, Arnaud Bourdin, Gilles Devouassoux, Camille Taillé, Frédéric de Blay, Christophe Leroyer, Antoine Beurnier, Gilles Garcia, Pierre‐Olivier Girodet, F.–X. Blanc, A. Magnan, Stéphanie Wanin, J. Just, R. Linde, Stefan Zielen, Karin Förster, Christian Geßner, Margret Jandl, Roland Buhl, Stephanie Korn, Marc Oliver Kornmann, Anneliese Linnhoff, Andrea Ludwig-Sengpiel, Martin Ehlers, Tibor Schmoller, Heiner Steffen, Martin Hoffmann, J Kirschner, Olaf Schmidt, Tobias Welte, Hilke Temme, Ori Wand, Amir Bar‐Shai, Gabriel Izbicki, Neville Berkman, Gershon Fink, David Shitrit, Yochai Adir, Piotr Kuna, Barbara Rewerska, Ewa Pisarczyk-Bogacka, О М Курбачева, Sergey L Mikhailov, M.P. Vasilev, Alexander Emelyanov, Siraj Wali, Amr S. Albanna, Richard N. van Zyl-Smit, Ismail Abdullah, Ismail Abdullah, David Bernhardi, Farzana Hoosen, Elvis M. Irusen, Ismail Kalla, Deepak Lakha, Essack Mitha, Visvakuren Naidoo, Haylene Nell, Trevenesan Padayachee, Jeevren Reddy, Friedrich Petrick, Eugene van der Walt, Zubar Fazal Ahmed Vawda, Hae‐Sim Park, Sang Haak Lee and 88 more - The Lancet Respiratory Medicine 2023 cited by 141

  12. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2023 cited by 285

  13. Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anneliese Linnhoff, Tobias Welte, Joachim Kirschner, Piotr Kuna, Barbara Rewerska, Ewa Pisarczyk-Bogacka, Sang Haak Lee, Byung Jae Lee, Heung-Woo Park, Jung-Won Park, Sook Young Lee, You Sook Cho, Kwan Ho Lee, Sevim Bavbek, Bilun Gemicioglu, Dane Ediger, Ilkay Koca Kalkan, Ismail Hanta, Arzu Yorgancioglu, Yevgeniya DytyatkovsKa, Yuriy M Mostovoy, Kyrylo Lebed, Oleh Yakovenko, David I Bernstein, Jeffrey P Tillinghast, Loretta Que, Jan Madison, Todd Rambasek, Kartik Shenoy, Charles A Thompson, Christopher M Chappel, Golda Hudes, Ehab Sorial, Shahrukh A Kureishy, Syed M Rehman, Njira Lugogo, Erika G Gonzalez, Fred C Umeh, Eric J Boren, Jason Sigmon, Hummayun Ismail, Arjun Mohan, Sandeep Bansal, Thomas D Kaelin - The Lancet Respiratory Medicine 2022 cited by 139

  14. Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 230

  15. openalex_id:w4223924695

    Authors: , , , , , , , , , , , , , , , , , , cited by 147

  16. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 448

  17. Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karsten Hiller, Katarzyna Placek, Christian Bode, Christoph Wilhelm - Nature 2022 cited by 155

  18. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sanne de Bruin, Endry H. T. Lim, Matthijs C. Brouwer, Pieter R. Tuinman, José Francisco Kerr Saraiva, Gernot Marx, Suzana M. Lobo, Rodrigo Boldo, Jesus Simon-Campos, Alexander D. Cornet, Anastasia Grebenyuk, Johannes Engelbrecht, Murimisi Mukansi, Philippe G. Jorens, Robert Zerbib, Simon Rückinger, Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C. Riedemann, Pierre Bulpa, Fabio Silvio Taccone, Greet Hermans, Marc Diltoer, Michaël Piagnerelli, Nikolaas De Neve, Antonio Freire, Felipe Dal‐Pizzol, Anna Karolina Marinho, Victor H. Sato, Clóvis Arns da Cunha, Mathilde Neuville, Jean Dellamonica, Djillali Annane, Antoine Roquilly, Jean Luc Diehl, Francis Schneider, Jean Paul Mira, Jean Baptiste Lascarrou, Luc Desmedt, Claire Dupuis, Carole Schwebel, Guillaume Thiéry, Matthias Gründling, Marc Moritz Berger, Tobias Welte, Michael Bauer, Ulrich Jaschinski, Klaus Matschke, Roberto Mercado-Longoría, Belinda Gomez Quintana, Jorge Alberto Zamudio-Lerma, Juan Moreno Hoyos Abril, Angel Aleman Marquez, Peter Pickkers, Luuk Otterspoor, Luis Hercilla Vásquez, Carlos Rafael Seas Ramos, Alejandro Peña Villalobos, Gonzalo Gianella Malca, Victoria Chávez, Victor Filimonov, В. В. Кулабухов, Pinak Acharya, Sjoerd A.M.E.G. Timmermans, Matthias H. Busch, Floor L. F. van Baarle, Rutger Koning, Liora ter Horst, Nora Chekrouni and 9 more - The Lancet Respiratory Medicine 2022 cited by 142

  19. DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ederlon Rezende, Caio Vinicius Gouvêa Jaoude, Ellen Pierre de Olivera, Vania Quinato Malacize, Claudio Stadnik, Eduarda Annoni Ramos, Graziela Regina Kist, Gynara Rezende Barbosa, Henrique Filik, Sabrina Nalin, Charlotte Suppli Ulrik, Casper Tidemandsen, Kjell Erik Julius Håkansson, Thomas Benfield, Karen Brorup Pedersen, Tobias Welte, Marcus Bachman, Mathias Stoll, Ilona Olzik, Natascha Scharf, Nicole Shearman, Isabell Pink, Anna Frey, Petra Schulze, Cyrus Sayehli, Dirk Weismann, Hartwig Klinker, Maria-Elisabeth Goebeler, Lars S. Maier, Florian Geismann, Frank Hanses, Judith Zeller, Julian Hupf, Matthias Lubnow, Sabine Sag, Sarah Ripfel, Steffen Pabel, Stilla Bauernfeind, Ulf Leisner, Florian Hitzenbichler, Ildikó Madurka, Dora Iharos, Krisztina Kormosoi Toth, Maria Hejja, Tamas Esze, Sushma Bhatnagar, Anant Mohan, Anuja Pandit, Balbir Kumar, Brajesh Kumar Ratre, Pawan Tiwari, Ram Singh, Saurabh Vig, Shweta Bhopale, S. Bhan, Akshay Budhraja, Ankit Agrawal, Srikanth V. Krishnamurthy, Ambika Srikanth, Kalaiyamishan Kaneesan, Mauila Raghavan Jaymohan Unnithan, Nagarajan Srinivasan, Nandagopal Velayuthaswamy, Senthil Kumar Mothu Gounder, Venkatraman Vaidyanathan, Amitabha Saha, Abhishek Bhattacharjee, Avijatri Datta, Adrián Rendón, Adrián Camacho Ortiz and 71 more - Infection 2022 cited by 83

  20. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tina Skjold, Ingrid Louise Titlestad, Auli Hakulinen, Maritta Kilpeläinen, M. Ben Hayoun, Philippe Bonniaud, Arnaud Bourdin, Pascal Chanez, Frédéric de Blay, Gaëtan Deslée, Gilles Devouassoux, A. Didier, Y. Douadi, Stéphanie Fry, Gilles Garcia, Pierre‐Olivier Girodet, Christophe Leroyer, A. Magnan, Guillaume Mahay, C. Nocent, Christophe Pison, Pauline-Marie Roux, Camille Taillé, Juliana-Angelica Tiotiu, Ekkehard Beck, Margret Jandl, Christian Kaehler, Frank Käßner, Frank Koesters, Juliane Kronsbein, Thomas Schaum, Christian Schulz, Dirk Skowasch, Christian Taube, Tobias Welte, A de Roux, Bianca Beghé, Francesco Blasi, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Cristiano Caruso, Angelo Guido Corsico, Elio Constantino, Nunzio Crimi, Piero Maestrelli, Francesco Menzella, Manlio Milanese, Alberto Papi, Girolamo Pelaia, Laura Pini, Pierachille Santus, Eleonora Savi, Nicola Scichilone, Gianenrico Senna, Giuseppe Spadaro, Adriano Vaghi, Steven Gans, Jurgen Hölters, Bas Langeveld, Willem R. Pieters, Gerald Staaks, Ilonka van Veen, Jan Willem van den Berg, Gunnar Einvik, Sverre Lehmann, Ismael Ali García, Carlos Almonacid, Irina Bobolea, Paloma Campo Mozo, Gustavo de Luiz and 127 more - The Lancet Respiratory Medicine 2020 cited by 175

  21. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takaya Maruyama, Rosario Menéndez, Mark L. Metersky, Donna Mildvan, Eric M. Mortensen, Michael S. Niederman, Mathias W. Pletz, Jordi Rello, Marcos I. Restrepo, Yuichiro Shindo, Antoní Torres, Grant Waterer, Brandon Webb, Tobias Welte, Martin Witzenrath, Richard G. Wunderink - CHEST Journal 2020 cited by 233

  22. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial

    Authors: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2022 cited by 106

  23. REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma

    Authors: , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2022 cited by 102

  24. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bin Cao, Yahya Shehabi, Jens‐Ulrik Stæhr Jensen, Caspar Corti, Jos A. H. van Oers, Albertus Beishuizen, Armand R. J. Girbes, Evelien de Jong, Matthias Briel, Beat Müeller - The Lancet Infectious Diseases 2017 cited by 473